Atlas Capital Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.8K | Hold |
110
| – | – | ﹤0.01% | 762 |
|
|
2025
Q1 | $11.1K | Hold |
110
| – | – | ﹤0.01% | 791 |
|
|
2024
Q4 | $9.83K | Hold |
110
| – | – | ﹤0.01% | 782 |
|
|
2024
Q3 | $9.22K | Hold |
110
| – | – | ﹤0.01% | 736 |
|
|
2024
Q2 | $8.47K | Hold |
110
| – | – | ﹤0.01% | 746 |
|
|
2024
Q1 | $7.53K | Hold |
110
| – | – | ﹤0.01% | 739 |
|
|
2023
Q4 | $6.36K | Hold |
110
| – | – | ﹤0.01% | 779 |
|
|
2023
Q3 | $5.81K | Hold |
110
| – | – | ﹤0.01% | 756 |
|
|
2023
Q2 | $5.95K | Hold |
110
| – | – | ﹤0.01% | 775 |
|
|
2023
Q1 | $5.5K | Hold |
110
| – | – | ﹤0.01% | 791 |
|
|
2022
Q4 | $5.09K | Hold |
110
| – | – | ﹤0.01% | 786 |
|
|
2022
Q3 | $4.26K | Sell |
110
-700
| -86% | -$27.1K | ﹤0.01% | 784 |
|
|
2022
Q2 | $30.2K | Hold |
810
| – | – | 0.01% | 627 |
|
|
2022
Q1 | $35.9K | Hold |
810
| – | – | 0.01% | 579 |
|
|
2021
Q4 | $34.4K | Sell |
810
-237
| -23% | -$10.1K | 0.01% | 578 |
|
|
2021
Q3 | $45.4K | Sell |
1,047
-4,826
| -82% | -$209K | 0.01% | 530 |
|
|
2021
Q2 | $251K | Buy |
5,873
+5,173
| +739% | +$221K | 0.04% | 324 |
|
|
2021
Q1 | $27.1K | Buy |
+700
| New | +$27.1K | 0.01% | 558 |
|
|
2019
Q1 | – | Sell |
-548
| Closed | -$19.4K | – | 566 |
|
|
2018
Q4 | $19.4K | Buy |
+548
| New | +$19.4K | 0.01% | 468 |
|